Selected Publications
- Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Paola Bianchimano, Paola Leone, Emma M. Smith, Cristina Gutierrez-Vazquez, Erli Wind-andersen, Gerold Bongers, Sebastian Cristancho, Howard L. Weiner, Jose C. Clemente, Stephanie K. Tankou. Brain, Behavior, and Immunity
- Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE. Paola Bianchimano, Kacper Iwanowski, Emma M. Smith, Adam Cantor, Paola Leone, Gerold Bongers, Carlos G. Gonzalez, Yoon Hongsup, Joshua Elias, Howard L. Weiner, Jose C. Clemente, Stephanie K. Tankou. iScience
- T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy. Anthony T. Reder, Olaf Stuve, Stephanie K. Tankou, Thomas P. Leist. Multiple Sclerosis Journal